Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Amortization - Intangibles: 2009-2024

Historic Amortization - Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $4.7 million.

  • Cumberland Pharmaceuticals' Amortization - Intangibles fell 6.37% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 42.76%. This contributed to the annual value of $4.7 million for FY2024, which is 41.40% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Amortization - Intangibles stood at $4.7 million for FY2024, which was down 41.40% from $8.1 million recorded in FY2023.
  • In the past 5 years, Cumberland Pharmaceuticals' Amortization - Intangibles registered a high of $8.1 million during FY2023, and its lowest value of $4.4 million during FY2021.
  • In the last 3 years, Cumberland Pharmaceuticals' Amortization - Intangibles had a median value of $5.1 million in 2022 and averaged $6.0 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Amortization - Intangibles soared by 59.90% in 2023, and later plummeted by 41.40% in 2024.
  • Cumberland Pharmaceuticals' Amortization - Intangibles (Yearly) stood at $4.4 million in 2020, then fell by 1.42% to $4.4 million in 2021, then increased by 15.92% to $5.1 million in 2022, then soared by 59.90% to $8.1 million in 2023, then crashed by 41.40% to $4.7 million in 2024.